Whether prehospital blood pressure control improves outcomes among patients with acute ischemic stroke is uncertain. This systematic review and meta-analysis aimed to evaluate the effect of prehospital blood pressure reduction treatment in patients with ischemic stroke.
Methods:
We searched PubMed, Embase, and the Cochrane Central Register of Controlled Trials for randomized controlled trials that compared prehospital blood pressure reduction treatment with usual treatment or no treatment in patients with stroke. The primary outcome was functional outcome, assessed with the distribution of modified Rankin Scale (mRS) at 90 days, while secondary outcome was mortality at 90 days.
Results:
Of 428 studies reviewed, three were appropriate for analysis, totaling 3878 patients. In patients with ischemic stroke, prehospital blood pressure reduction treatment was associated with higher mRS scores at 90 days (common odds ratio (OR) for worse mRS, OR: 1.27, 95% confidence interval (CI): 1.08–1.49) and increased risk of mortality at 90 days (OR: 1.28, 95% CI: 1.02–1.61) compared with the usual treatment.
Conclusion:
In patients with ischemic stroke, prehospital blood pressure reduction treatment was associated with a higher likelihood of poor functional outcome and an elevated risk of mortality.
WillmotMLeonardi-BeeJBathPM.High blood pressure in acute stroke and subsequent outcome: a systematic review. Hypertension2004; 43: 18–24.
2.
GreenbergSMZiaiWCCordonnierC, et al. 2022 Guideline for the management of patients with spontaneous intracerebral hemorrhage: a guideline from the American Heart Association/American Stroke Association. Stroke2022; 53: e282–e361.
3.
SandsetECAndersonCSBathPM, et al. European Stroke Organisation (ESO) guidelines on blood pressure management in acute ischaemic stroke and intracerebral haemorrhage. Eur Stroke J2021; 6: II.
4.
BowryRParkerSABratinaP, et al. Hemorrhage enlargement is more frequent in the first 2 hours: a prehospital mobile stroke unit study. Stroke2022; 53: 2352–2360.
5.
LiQWarrenADQureshiAI, et al. Ultra-early blood pressure reduction attenuates hematoma growth and improves outcome in intracerebral hemorrhage. Ann Neurol2020; 88: 388–395.
6.
LiGLinYYangJ, et al. Intensive ambulance-delivered blood-pressure reduction in hyperacute stroke. N Engl J Med2024; 390: 1862–1872.
7.
van den BergSAUniken VenemaSMReininkH, et al. Prehospital transdermal glyceryl trinitrate in patients with presumed acute stroke (MR ASAP): an ambulance-based, multicentre, randomised, open-label, blinded endpoint, phase 3 trial. Lancet Neurol2022; 21: 971–981.
8.
RIGHT-2 Investigators. Prehospital transdermal glyceryl trinitrate in patients with ultra-acute presumed stroke (RIGHT-2): an ambulance-based, randomised, sham-controlled, blinded, phase 3 trial. Lancet2019; 393: 1009–1020.
9.
PageMJMcKenzieJEBossuytPM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ2021; 372: n71.
10.
SterneJACSavovićJPageMJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ2019; 366: l4898.
11.
GuyattGHOxmanADVistGE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ2008; 336: 924–926.
12.
HigginsJPThompsonSG.Quantifying heterogeneity in a meta-analysis. Stat Med2002; 21: 1539–1558.
13.
EggerMDavey SmithGSchneiderMMinderC.Bias in meta-analysis detected by a simple, graphical test. BMJ1997; 315: 629–634.
14.
BeggCBMazumdarM.Operating characteristics of a rank correlation test for publication bias. Biometrics1994; 50: 1088–1101.
15.
SaverJLStarkmanSEcksteinM, et al. Prehospital use of magnesium sulfate as neuroprotection in acute stroke. N Engl J Med2015; 372: 528–536.
16.
LeeMOvbiageleBHongKS, et al. Effect of blood pressure lowering in early ischemic stroke: meta-analysis. Stroke2015; 46: 1883–1889.
17.
SchraderJLüdersSKulschewskiA, et al. The ACCESS study: evaluation of acute candesartan cilexetil therapy in stroke survivors. Stroke2003; 34: 1699–1703.
18.
HeJZhangYXuT, et al. Effects of immediate blood pressure reduction on death and major disability in patients with acute ischemic stroke: the CATIS randomized clinical trial. JAMA2014; 311: 479–489.
19.
PotterJFRobinsonTGFordGA, et al. Controlling hypertension and hypotension immediately post-stroke (CHHIPS): a randomised, placebo-controlled, double-blind pilot trial. Lancet Neurol2009; 8: 48–56.
20.
RobinsonTGPotterJFFordGA, et al. Effects of antihypertensive treatment after acute stroke in the Continue or Stop Post-Stroke Antihypertensives Collaborative Study (COSSACS): a prospective, randomised, open, blinded-endpoint trial. Lancet Neurol2010; 9: 767–775.
21.
ENOS Trial Investigators. Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): a partial-factorial randomised controlled trial. Lancet2015; 385: 617–628.
22.
EvesonDJRobinsonTGPotterJF.Lisinopril for the treatment of hypertension within the first 24 hours of acute ischemic stroke and follow-up. Am J Hypertens2007; 20: 270–277.
23.
AhmedNNäsmanPWahlgrenNG.Effect of intravenous nimodipine on blood pressure and outcome after acute stroke. Stroke2000; 31: 1250–1255.
24.
KasteMFogelholmREriläT, et al. A randomized, double-blind, placebo-controlled trial of nimodipine in acute ischemic hemispheric stroke. Stroke1994; 25: 1348–1353.
25.
SandsetECBathPMBoysenG, et al. The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial. Lancet2011; 377: 741–750.
26.
OhMSYuKHHongKS, et al. Modest blood pressure reduction with valsartan in acute ischemic stroke: a prospective, randomized, open-label, blinded-end-point trial. Int J Stroke2015; 10: 745–751.
27.
HornJde HaanRJVermeulenMLimburgM.Very Early Nimodipine Use in Stroke (VENUS): a randomized, double-blind, placebo-controlled trial. Stroke2001; 32: 461–465.
28.
BathPMMartinRHPaleschY, et al. Effect of telmisartan on functional outcome, recurrence, and blood pressure in patients with acute mild ischemic stroke: a PRoFESS subgroup analysis. Stroke2009; 40: 3541–3546.
29.
AnkolekarSFullerMCrossI, et al. Feasibility of an ambulance-based stroke trial, and safety of glyceryl trinitrate in ultra-acute stroke: the rapid intervention with glyceryl trinitrate in Hypertensive Stroke Trial (RIGHT, ISRCTN66434824). Stroke2013; 44: 3120–3128.
30.
SaverJL.Blood pressure management in early ischemic stroke. JAMA2014; 311: 469–470.
31.
KleindorferDOTowfighiAChaturvediS, et al. 2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association/American Stroke Association. Stroke2021; 52: e364–e467.
32.
LiuLXieXPanY, et al. Early versus delayed antihypertensive treatment in patients with acute ischaemic stroke: multicentre, open label, randomised, controlled trial. BMJ2023; 383: e076448.
33.
WeiYXieXPanY, et al. Early vs delayed antihypertensive treatment in acute single subcortical infarction: a secondary analysis of the CATIS-2 randomized clinical trial. JAMA Netw Open2024; 7: e2430820.
34.
CarcelCAndersonCS.Timing of blood pressure lowering in acute ischemic stroke. Curr Atheroscler Rep2015; 17: 42.
35.
WillmotMGhadamiAWhysallBClarkeWWardlawJBathPM.Transdermal glyceryl trinitrate lowers blood pressure and maintains cerebral blood flow in recent stroke. Hypertension2006; 47: 1209–1215.
36.
KateMGioiaLAsdaghiN, et al. Nitroglycerin is not associated with improved cerebral perfusion in acute ischemic stroke. Can J Neurol Sci2021; 48: 349–357.
37.
Van AkenHPuchsteinCAngerCLawinP. The influence of urapidil, a new antihypertensive agent, on cerebral perfusion pressure in dogs with and without intracranial hypertension. Intensive Care Med1983; 9: 123–126.
38.
FischerUCooneyMTBullLM, et al. Acute post-stroke blood pressure relative to premorbid levels in intracerebral haemorrhage versus major ischaemic stroke: a population-based study. Lancet Neurol2014; 13: 374–384.
39.
SandsetEC.Blood pressure in acute stroke. Lancet Neurol2014; 13: 342–343.
40.
ArimaHHuangYWangJG, et al. Earlier blood pressure-lowering and greater attenuation of hematoma growth in acute intracerebral hemorrhage: INTERACT pilot phase. Stroke2012; 43: 2236–2238.
41.
GrottaJCYamalJMParkerSA, et al. Prospective, multicenter, controlled trial of mobile stroke units. N Engl J Med2021; 385: 971–981.
42.
WalshKB.Non-invasive sensor technology for prehospital stroke diagnosis: current status and future directions. Int J Stroke2019; 14: 592–602.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
